Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

NCT06531447 is registered in ClinicalTrials.gov with The National Center of Oncology, Azerbaijan as lead sponsor.

NCT NCT06531447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
Lead sponsor
The National Center of Oncology, Azerbaijan
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 31, 2014
Completion date
May 31, 2027
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer